Sio Gene Therapies Inc. / Estimates

Fiscal Year	Revenue	Net income	Net margin	Free cash flow	FCF margin
2022	€0.00 +NaN%	-€61.93M +121.7%	N/A	-€51.39M +29.1%	N/A
2021	€0.00 +NaN%	-€27.94M -55.4%	N/A	-€39.80M -31.3%	N/A
2020	€0.00 +NaN%	-€62.57M -43.7%	N/A	-€57.91M -49.8%	N/A
2019	€0.00 +NaN%	-€111.20M -41.8%	N/A	-€115.45M -28.0%	N/A
2018	€0.00 +NaN%	-€190.90M +22.4%	N/A	-€160.30M +66.1%	N/A
2017	€0.00 +NaN%	-€155.90M +35.9%	N/A	-€96.50M +133.3%	N/A
2016	€0.00	-€114.71M	N/A	-€41.36M	N/A